MedPath

Anti-GD2 monoclonal antibody 3F8

Generic Name
Anti-GD2 monoclonal antibody 3F8
Brand Names
-
Drug Type
Biotech
Chemical Formula
-
CAS Number
-
Unique Ingredient Identifier
3GFS72WN4M
Background

Anti-GD2 monoclonal antibody 3F8 is under investigation in clinical trial NCT00089258 (Biological Therapy in Treating Patients With Neuroblastoma That Has Not Responded to Previous Treatment).

Associated Conditions
-
Associated Therapies
-
© Copyright 2025. All Rights Reserved by MedPath